CIK 1616824
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 76.69% | 8 |
| Specialty Retail | 12.67% | 3 |
| Health Care Equipment & Supplies | 4.70% | 1 |
| Unclassified | 4.13% | 2 |
| Food Products | 1.81% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | ACRS | Aclaris Therapeutics, Inc. | Health Care | 34.38% |
| 2 | AVIR | Atea Pharmaceuticals, Inc. | Health Care | 24.43% |
| 3 | ORMP | ORAMED PHARMACEUTICALS INC. | Health Care | 6.93% |
| 4 | TLYS | TILLY'S, INC. | Consumer Discretionary | 5.60% |
| 5 | OM | Outset Medical, Inc. | Health Care | 4.70% |
| 6 | PMVP | PMV Pharmaceuticals, Inc. | Health Care | 4.24% |
| 7 | KMX | CARMAX INC | Consumer Discretionary | 4.15% |
| 8 | KEZAR LIFE SCIENCES INC | Unclassified | 3.44% | |
| 9 | TIL | Instil Bio, Inc. | Health Care | 3.42% |
| 10 | TGT | TARGET CORP | Consumer Discretionary | 2.92% |
13/15 names classified · sector 95.9% of weight · industry 95.9% · mkt cap 95.2%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 95.9% of the book is sector-classified (unclassified names shown, never dropped).
Only 21% of book weight classified — the grid is NOT representative of the whole book.
Classified: 21.4% of book weight (5/15 names) · unclassified 78.6%: ACRS, AVIR, OM, PMVP, , TIL, JANX, PLRX, CNTB, IMA. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | ACRSACLARIS THERAPEUTICS INC | 14,250,000 | $53M | 34.4% | HOLD |
| 2 | AVIRATEA PHARMACEUTICALS INC | 7,058,657 | $38M | 24.4% | TRIM −6% |
| 3 | ORMPORAMED PHARMACEUTICALS INC | 3,167,231 | $11M | 6.9% | HOLD |
| 4 | TLYSTILLYS INC | 2,150,000 | $9M | 5.6% | NEW |
| 5 | OMOUTSET MED INC | 1,902,201 | $7M | 4.7% | ADD 250% |
| 6 | PMVPPMV PHARMACEUTICALS INC | 5,320,000 | $7M | 4.2% | HOLD |
| 7 | KMXCARMAX INC | 155,000 | $6M | 4.1% | HOLD |
| 8 | KEZAR LIFE SCIENCES INC | 720,787 | $5M | 3.4% | HOLD |
| 9 | TILINSTIL BIO INC | 645,600 | $5M | 3.4% | HOLD |
| 10 | TGTTARGET CORP | 37,500 | $5M | 2.9% | HOLD |
| 11 | KHCKRAFT HEINZ CO | 125,000 | $3M | 1.8% | NEW |
| 12 | JANXJANUX THERAPEUTICS INC | 154,961 | $2M | 1.4% | NEW |
| 13 | PLRXPLIANT THERAPEUTICS INC | 1,546,137 | $2M | 1.3% | HOLD |
| 14 | CNTBCONNECT BIOPHARMA HLDGS LTD | 408,887 | $1M | 0.7% | HOLD |
| 15 | IMAIMAGENEBIO INC | 200,730 | $1M | 0.6% | ADD 13% |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| ACRSACLARIS THERAPEUTICS INC | 14.3M | 14.3M | 14.3M | 14.3M | 14.3M | 14.3M | $53M |
| AVIRATEA PHARMACEUTICALS INC | 7.6M | 7.6M | 7.6M | 7.5M | 7.5M | 7.1M | $38M |
| ORMPORAMED PHARMACEUTICALS INC | 2.6M | 3.0M | 3.1M | 3.2M | 3.2M | 3.2M | $11M |
| TLYSTILLYS INC | — | — | — | — | — | 2.1M | $9M |
| OMOUTSET MED INC | — | — | — | — | 543K | 1.9M | $7M |
| PMVPPMV PHARMACEUTICALS INC | 3.5M | 3.7M | 5.0M | 5.3M | 5.3M | 5.3M | $7M |
| KMXCARMAX INC | — | — | — | — | 155K | 155K | $6M |
| KEZAR LIFE SCIENCES INC | 49K | 408K | 635K | 721K | 721K | 721K | $5M |
| TILINSTIL BIO INC | 400K | 417K | 535K | 646K | 646K | 646K | $5M |
| TGTTARGET CORP | — | — | — | 10K | 38K | 38K | $5M |
| KHCKRAFT HEINZ CO | — | — | — | — | — | 125K | $3M |
| JANXJANUX THERAPEUTICS INC | — | — | — | — | — | 155K | $2M |
| PLRXPLIANT THERAPEUTICS INC | — | — | — | — | 1.5M | 1.5M | $2M |
| CNTBCONNECT BIOPHARMA HLDGS LTD | — | — | — | 1.3M | 409K | 409K | $1M |
| IMAIMAGENEBIO INC | — | — | — | 183K | 177K | 201K | $1M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
